Valsartan, losartan and irbesartan
5 stories tracked · latest
1,417
Case tracking for the Valsartan, losartan and irbesartan matter, current through August 11, 2026, plus any additional news coverage found automatically below. Allegations may be disputed; a listing does not establish liability or individual eligibility.
Recent coverage
$15.2M Valsartan, Losartan and Irbesartan class action settlement - Top Class Actions
A class action involving valsartan, losartan, and irbesartan has reached a $15.2 million settlement.
Claim form open in $1.9M Vivimed Losartan drug contamination class action settlement - Claim Depot
Claim forms are available for a $1.9 million class action settlement concerning alleged contamination of Vivimed Losartan.
Hetero settles Valsartan drug contamination class action for $11.37M - Claim Depot
Hetero has agreed to a $11.37 million settlement resolving a class action concerning contaminated valsartan medication.
Drug Manufacturer Agrees To $1.89M Settlement To End Claims In Losartan MDL - Mealey's
A drug manufacturer agreed to a $1.89 million settlement resolving claims in the Losartan multidistrict litigation.
Vivimed To Pay $1.9M To End Losartan Economic Loss Claims - Law360
Vivimed has agreed to pay $1.9 million to resolve economic-loss claims concerning losartan.
Curated matter facts are cited to public reporting and official sources and are not GPT-generated. Coverage above aggregates public news reporting using the GDELT news database and Google News, updated automatically without human review. It is general information, not legal advice, and does not indicate CaseValuation.com represents or is affiliated with any party, law firm, or plaintiff named above. CaseValuation.com is not a law firm. If you believe you're affected by one of these matters, consult a licensed attorney.